$1.715
-0.044 (-2.56%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ZNTL Prediction & Forecast by Similar Chart Analysis
Alphio's ZNTL stock price prediction model matches the current Zentalis Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.72 (+0.41%). The 1-week path is $1.66 (-2.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Zentalis Pharmaceuticals Inc Stock?
Zentalis Pharmaceuticals Inc is not a good buy right now. The current price is $1.85, which is significantly below its 52-week high of $6.95, indicating a substantial decline. The RSI is at 22.255, suggesting the stock is oversold and may not recover soon. Additionally, the company has reported continuous losses, with a net income of -$42,286,000 in Q2 2026 and a forward P/E of 0, reflecting lack of earnings visibility. The main risk is the recent earnings miss, where the EPS was -$0.59, missing estimates by $0.10, which could further undermine investor confidence.
ZNTL stock price ended at $1.72 on Thursday, after losing -2.56%
Zentalis Pharmaceuticals Inc (ZNTL) last closed at $1.71, losing -2.84%. These facts feed the 1-day and 1-week ZNTL price prediction above.
Forecast Drivers
Zentalis Pharmaceuticals Inc (ZNTL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ZNTL, ranked by similarity.
Seasonality analysis for ZNTL
Historically the probability of a positive November return for ZNTL is 9.30%. January offers the highest probability of a positive month at 36.07%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ZNTL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.11 | $1.34 | $1.34 | -21.38% |
| Dec 2026 | $1.37 | $1.53 | $1.76 | -10.29% |
In 2026, Zentalis Pharmaceuticals Inc (ZNTL) is projected to range from $1.11 to $1.76.
Zentalis Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Zentalis Pharmaceuticals Inc is projected to average $1.34, with a low of $1.11 and high of $1.34.
In Dec 2026, Zentalis Pharmaceuticals Inc is projected to average $1.53, with a low of $1.37 and high of $1.76.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.